Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis

<div>Receiver operating characteristic curve of serum CysC (▪▪▪▪<span class="inline" id="M3"></span>) and MELD score (<b>—</b>) at admission for predicting 3-month mortality in HBV-DeCi patients.</div>

BioMed Research International

fig2

Figure 2

Figure 2: Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis 